Governance Novo Nordisk A/S

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 16:20:00 10/09/2024 BST			5-day change	1st Jan Change
875.30 ^DKK	-1.32%		-5.62%	+25.38%

09-10	Health Care Up on Defensive Bias -- Health Care Roundup	DJ
09-10	Weight-loss market to see 16 new drugs by 2029, report estimates	RE

Executive Committee: Novo Nordisk A/S

Manager

Positions heldSince

Lars Fruergaard Jorgensen

58 year

Chief Executive Officer	31/12/2016
President	31/12/2016

Tania Sabroe

47 year

Human Resources Officer

31/12/2006

Daniel Bohsen

Investor Relations Contact

29/02/2020

Robin Evers

General Counsel

29/02/2024

Marcus Schindler

58 year

Chief Tech/Sci/R&D Officer

28/02/2021

Stephen Gough

Chief Tech/Sci/R&D Officer

30/09/2015

Karsten Munk Knudsen

53 year

Director of Finance/CFO

14/02/2018

Maziar Mike Doustdar

54 year

Chief Operating Officer

31/08/2016

Henrik Ehlers Wulff

54 year

Chief Tech/Sci/R&D Officer

31/12/2018

Composition of the Board of Directors: Novo Nordisk A/S

Director

CommitteesSince

Helge Lund

62 year

Nominating Committee Chair	21/03/2018
HR Committee Chair	31/12/2018
Governance Committee Chair	31/12/2018

Henrik Poulsen

57 year

Audit Committee	24/03/2021
Compensation Committee Chair	24/03/2021
Compensation Committee	31/12/2021
Nominating Committee Chair	31/12/2021

Andreas Fibig

62 year

Audit Committee	09/01/2023
Governance Committee	09/01/2023
Nominating Committee	09/01/2023

Sylvie Grégoire

62 year

Audit Committee	18/03/2015
Nominating Committee	18/03/2015

Kasim Kutay

59 year

Nominating Committee	28/01/2024
Compensation Committee	28/01/2024

Martin MacKay

68 year

Finance Committee
Compensation Committee	31/12/2020

Laurence Debroux

55 year

Audit Committee Chair	31/12/2020
Compensation Committee	31/12/2020

Liselotte Hyveled

58 year

Governance Committee	06/05/2024
Nominating Committee	06/05/2024

Mette Bøjer Jensen

49 year

Audit Committee

28/02/2022

Thomas Rantzau

52 year

Nominating Committee

28/02/2022

Elisabeth Christensen

59 year

Compensation Committee

23/03/2022

Christina Law

57 year

Audit Committee

28/02/2022

Latest Appointments: Novo Nordisk A/S

Health Care Declines as Risk Aversion Weighs - Health Care Roundup	09-05	DJ
Sagimet Biosciences Inc. Announces Appointment of Board of Directors	08-01	CI
SpringWorks Therapeutics, Inc. Appoints Dr. Martin Mackay to Its Board of Directors	07-29	CI
Hims & Hers Health, Inc. Announces Appointment of Kåre Schultz to Board of Directors	07-22	CI
Adocia appoints Director of Operations	06-04	CF
Germany's Evotec appoints Christian Wojczewski as CEO	04-23	RE
Global markets live: Darktrace, Merck, Meta, Apple, Eli Lilly...	03-07

More news

Former Officers and Directors: Novo Nordisk A/S

Insider

Positions held

SinceUntil

Anne Marie Handrup Kverneland

Director/Board Member

31/12/1999

23/03/2022

Stig Strøbæk

Director/Board Member

31/12/1997

23/03/2022

Jesper Brandgaard

Director of Finance/CFO	31/10/2000	14/02/2018
General Counsel	14/02/2018	31/03/2019

Göran Albert Ando

Director/Board Member	31/12/2004	19/03/2013
Chairman	19/03/2013	31/12/2017
Chief Tech/Sci/R&D Officer	07/06/2010	07/11/2011

Lars Rebien Sørensen

Chief Executive Officer	31/10/2000	31/12/2016
President	31/10/2000	31/12/2016

Kåre Schultz

Chief Operating Officer	07/06/2010	29/04/2015
President	31/12/1988	29/04/2015

Hannu Ragnvald Ryöppönen

Director/Board Member	28/02/2009	18/03/2015
Independent Dir/Board Member	15/08/2011	18/03/2015

Lise Kingo

Human Resources Officer	08/11/2011	31/10/2014
Corporate Officer/Principal	07/06/2010	08/11/2011

Sten Scheibye

Chairman	31/12/2002	19/03/2013
Independent Dir/Board Member	31/12/2002	01/05/2012

Per Toft Valstorp

Corporate Officer/Principal

08/07/2009

31/12/2012

Jørgen Wedel

Director/Board Member

31/12/1999

20/03/2012

Pamela Kirby

Director/Board Member

31/12/2007

22/03/2011

Johnny Henriksen

Director/Board Member

23/03/2010

Ulrik Joakim Hjulmand-Lassen

Director/Board Member

29/03/2010

Kurt W. Briner

Director/Board Member

17/03/2009

Peter Gerhardsson

Corporate Officer/Principal

30/04/2008

Niels Jacobsen

Director/Board Member

31/12/1999

31/12/2007

Jan Ulf Sigvar J. Johansson

Director/Board Member

31/12/1997

28/02/2005

Henrik Gürtler

Director/Board Member

31/12/2004

Robert Frederick Caspari

Corporate Officer/Principal

31/12/2003

Finn M. Ulrich

Chief Tech/Sci/R&D Officer

31/12/1995

31/12/2003

Marianne Kock

Corporate Officer/Principal

31/12/1984

31/12/2001

Jack Nielsen

Corporate Officer/Principal

31/12/1989

31/12/2000

Valeta A. Gregg

Corporate Officer/Principal

31/12/1995

31/12/2000

Anders Hedegaard

Sales & Marketing

31/12/1990

31/12/1999

Kirsten Drejer

Corporate Officer/Principal

31/12/1990

31/12/1999

Grethe Nørskov Rasmussen

Corporate Officer/Principal

31/12/1988

Martin Olin

Director of Finance/CFO

31/12/1995

31/12/1999

Thomas Feldthus

Corporate Officer/Principal

31/12/1995

31/12/1998

Hanne Damgaard Jensen

Corporate Officer/Principal

31/12/1994

31/12/1998

Christian Hansen

Corporate Officer/Principal

31/12/1991

31/12/1998

Jan Öhrström

Sales & Marketing

31/12/1989

31/12/1998

Anker Gunvald Lundemose

Corporate Officer/Principal

31/05/1994

31/10/1998

Peter Nordkild

Corporate Officer/Principal

31/12/1995

Carsten Hellmann

Corporate Officer/Principal	31/12/1995	-
Sales & Marketing	31/12/1992	30/12/1995

Harry Penner

General Counsel	31/12/1984	31/12/1987
Corporate Officer/Principal	31/12/1987	31/12/1992

Leif Kongerslev

Corporate Officer/Principal

31/12/1988

Johan Selmer

Corporate Officer/Principal

31/12/1982

Joe A. Young

Sales & Marketing

Niels Jonas Heilskov Graversen

Corporate Officer/Principal

Michael J. Dwyer

Sales & Marketing

Torben Nissen

Corporate Officer/Principal

Lotte Sønderbjerg

Corporate Secretary

Søren Bregenholt

Chief Investment Officer	08/06/2010	-
Corporate Officer/Principal	-	08/06/2010

Jørgen Ulrik Vejlsgaard

Corporate Officer/Principal

Kenneth William Harlow

Corporate Officer/Principal

Mads Fischer Rasmussen

Corporate Officer/Principal

Karin Hannader

Corporate Officer/Principal

Stephen Farr

Chief Tech/Sci/R&D Officer

Casper Breum

Corporate Officer/Principal

Patrick Michael Round

Corporate Officer/Principal

Thue Walter Schwartz

Chief Tech/Sci/R&D Officer

Mads Dall

Corporate Officer/Principal

Ganesh Iyer

Corporate Officer/Principal

Pál Helmich

Corporate Officer/Principal

Tim Kehling Pedersen

Corporate Officer/Principal

Christian Hemmingsen

Corporate Officer/Principal

Thomas Lander

Corporate Officer/Principal

Lene Gerlach

Corporate Officer/Principal

Jens Ole Pedersen

Corporate Officer/Principal

Jens Morten Fogh

Chief Tech/Sci/R&D Officer

Ib Schneider

Corporate Officer/Principal

Mike Rulis

Public Communications Contact

Jaques Arend

Corporate Officer/Principal

Jakob Dynnes Hansen

Corporate Officer/Principal

Steen Klysner

Corporate Officer/Principal

Hans Schambye

Corporate Officer/Principal

Esper Boel

Corporate Officer/Principal

Sam Lindgren

Corporate Officer/Principal

Niels Hvid

Corporate Officer/Principal

Martin O. Andersen

Director of Finance/CFO

Mads Buhl Axelsen

Corporate Officer/Principal

Bolette Wildt

General Counsel	-	13/07/2011
Corporate Officer/Principal	13/07/2011	-

Claus Kühl

Corporate Officer/Principal

Ole Thastrup

Corporate Officer/Principal

Peter W. Ravn

Corporate Officer/Principal

Jens Frederik Lage Hansen

Sales & Marketing

Jeppe Vesti Christensen

Corporate Officer/Principal

Per Bo Pedersen Fischer

Corporate Officer/Principal

Mads Øvlisen

Chairman

Grith Hagel

Corporate Officer/Principal

Stephan Christgau

Chief Tech/Sci/R&D Officer

Christian Meyer

Corporate Officer/Principal

Henrik Dalbøge

Corporate Officer/Principal

Mads Veggerby Lausten

Public Communications Contact

Tina Kragh-Jakobsen

Corporate Officer/Principal

Jürgen Langhärig

Corporate Officer/Principal

Mogens Vang Rasmussen

Corporate Officer/Principal

Anders Pedersen

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	21
Female	10

Of which Executive Committee

Male	8
Female	1

Of which Directors

Male	7
Female	5

ESG Refinitiv

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).

Employees

69,260

Sector

Pharmaceuticals

Calendar

06/11/2024 - Q3 2024 Earnings Release

Related indices

STOXX Europe 600 Index (EUR)

More about the company

Departures of Key Persons

Mads Øvlisen

Chairman

Sten Scheibye

Chairman

31/12/2002 19/03/2013

Lars Rebien Sørensen

Chief Executive Officer

31/10/2000 31/12/2016

Göran Albert Ando

Chairman

19/03/2013 31/12/2017

Governance Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Pharmaceuticals

Executive Committee: Novo Nordisk A/S

Composition of the Board of Directors: Novo Nordisk A/S

Latest Appointments: Novo Nordisk A/S

Former Officers and Directors: Novo Nordisk A/S

Age distribution of managers

Parity Men Women

Environment

Governance

Controversy

Company Profile

Departures of Key Persons

Governance Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Pharmaceuticals

Executive Committee: Novo Nordisk A/S

Composition of the Board of Directors: Novo Nordisk A/S

Latest Appointments: Novo Nordisk A/S

Former Officers and Directors: Novo Nordisk A/S

Age distribution of managers

Parity Men Women

Environment

Social

Governance

Controversy

Company Profile

Departures of Key Persons